Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1840671A details a bio-catalytic route for (R)-mandelic acid using Brevibacterium flavum. Offers high optical purity and greener manufacturing for pharmaceutical supply chains.
Novel method for (7S)-5-azaspiro[2.4]heptane-7-ylcarbamate tert-butyl ester. High optical purity, scalable process, cost-effective supply chain solutions for global pharma.
Novel lacosamide synthesis avoiding toxic reagents. High yield, scalable process for reliable API intermediate supply chain partners.
Patent CN113979975A details a metal-free chiral phosphoric acid catalyzed kinetic resolution for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability.
Patent CN104926671A enables high-yield D-phenylalanine production with reduced costs and superior purity for pharmaceutical supply chains globally.
Patent CN109628504A details a biphasic microbial resolution method. This technology enhances purity and yield for pharmaceutical intermediates while offering supply chain cost advantages.
Novel 5-step route for Ozanimod intermediates reduces cost and improves safety. Ideal for API intermediates manufacturing and supply chain optimization.
Novel nickel chelate synthesis enhances Maraviroc intermediate purity and yield while reducing environmental waste for reliable pharmaceutical supply chains.
Patent CN101910101A reveals a novel aliphatic hydrocarbon recrystallization method boosting optical purity to >99% ee for pharmaceutical intermediates efficiently.
Advanced synthesis of optically active 1-amino-2-vinylcyclopropane carboxylic acid esters via chiral resolution. Reliable pharmaceutical intermediate supplier offering cost-effective antiviral API precursors.
Novel synthesis of antiviral entecavir using naphthyl silane protection. Reduces cost and improves scalability for pharmaceutical manufacturing.
Novel patent CN106008316A offers cost-effective Ledipasvir intermediate synthesis. Enhances supply chain reliability and reduces manufacturing complexity for global buyers.
Novel 3-step chiral synthesis of PE phospholipid intermediate. High yield, mild conditions, scalable process for drug delivery systems.
Patent CN114835541A details a Pd-catalyzed method for high-yield chiral allenoic acids. Offers superior atom economy and scalability for pharmaceutical intermediate manufacturing.
Patent CN101302543A reveals a microbial method for high-purity (S)-phenylethylene glycol. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN101679295A discloses novel hydantoins for enantiomerically pure amino acids, enabling cost-effective Ramipril and Perindopril manufacturing.
Discover a novel asymmetric synthesis method for Sitagliptin base using L-DTTA. Eliminate noble metals and high-pressure hydrogenation for safer, scalable pharmaceutical manufacturing.
Patent CN108558715A details high-yield route. Reduces cost and environmental impact for pharmaceutical intermediates manufacturing significantly.
Novel epoxidation-ring opening route for antiviral intermediates. Reduces cost and improves purity compared to lithium aluminum hydride methods. Reliable supplier.
Patent CN101570550A details a scalable, chromatography-free route for chiral ferrocene ligands, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.